![Daniel-Adriano Silva](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel-Adriano Silva was the founder who started Neoleukin Therapeutics, Inc. in 2003, where he held the title of Vice President-Research until 2021.
He obtained an undergraduate degree from Universidad Nacional Autónoma de México.
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROGENE INC. | Fondateur | 01/03/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Universidad Nacional Autónoma de México
 Universidad Nacional Autónoma de México Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
